Probuphine is the first buprenorphine implant approved for the maintenance treatment of opioid dependence.
In adults, past exposure to marijuana was associated with worse verbal memory.
For clinicians who struggle with substance abuse and other mental health problems, impaired provider programs offer a safe, supportive space where they can recover.
Use of psychoactive drugs may be reduced through a combination of interactions with primary care physicians and follow-up calls from coaches.
A new formulation of intranasal naloxone - marketed as Narcan - has been FDA approved to help combat opioid abuse in the United States.
The American Academy of Family Physicians suggests the prescription of naloxone to the family and friend of patients who are at risk of opioid overdose.
Emergency providers need to make every effort to be responsible prescribers.
A comprehensive approach is needed to improve prescribing practices and ultimately reduce opioid abuse and related overdose death rates across the country.
Learn how to identify and treat opioid abuse, withdrawal, and dependence.
Providers need to address the overuse of prescription narcotics in the emergency room.
Recognizing red flag symptoms, such as anxiety, depression, and increased substance use, is important in helping victims who are reluctant to report the assault.
Emergency-department initiated buprenorphine treatment may increase addiction treatment and decrease opioid use in patients with opioid dependence .
"Flakka," a synthetic stimulant, can cause violent and unpredictable behavior.
White and Native American men had the highest rates of lifetime drinking problems - 33% and 43%, respectively.
Use of a new designer drug, a synthetic version of cathinone, appears to be on the rise.
HIV-positive men that use stimulants show no greater mortality risk after initiating highly active antiretroviral therapy (HAART).
Pharmacies will be prohibited from filling hydrocodone prescriptions delivered over the phone or via fax. eScripts can only be used in states where they are permitted.
New guidelines offer strategies for clinicians on how to effectively and safely manage opioid prescription use in chronic noncancer pain patients.
A federal report revealed the number of teens reporting illicit drug use fell in 2013.
Researchers found that young people were unaware about the risks associated with prescription opioid abuse and call for better outreach strategies and overdose prevention programs.
How can a clinician distinguish chronic pancreatitis from acute pancreatitis in a patient with alcohol-abuse history?
Adolescents reporting withdrawal and a drug problem improved at a greater rate compared with those who did not.
States that have enacted medical cannabis laws have seen an overall 24.8% mean drop in state-level opioid overdose mortality rates.
Following a spike in hydrocodone painkillers addiction, the federal government is restricting access to the opiate.
Spikes noted among young and middle-age adults.
The odds of severe memory impairment more than doubled with a history of alcohol use disorders.
The medication is designed to deter abuse of the drug by snorting or injection.
After a patient sought care for his opioid dependency, this provider was thanked for putting the patient's family back together.
When used as prescribed, these drugs are not addictive. However, abuse is on the rise, and clinicians need to be able to identify the signs.
Ask patients how many times in the past year they have used an illegal drug or prescription medication for nonmedical reasons.